Vincenzo Di Lauro

Corrigendum to "Association between chemotherapy use and prognosis in young patients with stage I-II ER+/HER2-negative breast cancer according to Prosigna®: An international real-world analysis with propensity-score matching" [Eur J Cancer 242 (2026) 116818].

Journal: European journal of cancer (Oxford, England : 1990)

Published: June 06, 2026

CDK4/6i in the Underrepresented Histological Subtypes of HR±/HER2- Metastatic Breast Cancer: A Real-World Cohort Study of Effectiveness and Safety.

Journal: Clinical breast cancer

Published: April 22, 2026

Analysis of Large Language Model Decision Making in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer.

Journal: JCO clinical cancer informatics

Published: March 06, 2026

Elacestrant in metastatic breast cancer: current advancements and future perspectives.

Journal: Expert review of anticancer therapy

Published: December 29, 2025

Association between chemotherapy use and prognosis in young patients with stage I-II ER+ /HER2-negative breast cancer according to Prosigna®: An international real-world analysis with propensity-score matching.

Journal: European journal of cancer (Oxford, England : 1990)

Published: December 18, 2025

Pharmacologic Features, Clinical Applications, and Drug Safety Evaluation of Inavolisib in the Treatment of Metastatic Breast Cancer.

Journal: Clinical breast cancer

Published: December 01, 2025

Healthful and Unhealthful Plant-Based Diets and Their Association with Cardiometabolic Targets in Women Diagnosed with Breast Cancer: A Cross-Sectional Analysis of a Lifestyle Trial.

Journal: Nutrients

Published: October 30, 2025

Vitamin D Supplementation and Testosterone Levels in Breast Cancer Survivors.

Journal: International journal of molecular sciences

Published: September 11, 2025

Datopotamab deruxtecan: rational strategies, novel advancements, challenges, and future perspectives.

Journal: Cancer treatment reviews

Published: August 21, 2025

Breast Immunology Network: Toward a Multidisciplinary and Integrated Model for Breast Cancer Care in Italy.

Journal: Cancers

Published: July 14, 2025

Insights on the association of anthropometric and metabolic variables with tumor features and genomic risk in luminal early breast cancer: Results of a multicentric prospective study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: February 24, 2025

The multidisciplinary management of HER2-positive breast cancer brain metastases: from new biological insights to future therapeutic options.

Journal: Frontiers in oncology

Published: June 11, 2024

Corrigendum to "Association between chemotherapy use and prognosis in young patients with stage I-II ER+/HER2-negative breast cancer according to Prosigna®: An international real-world analysis with propensity-score matching" [Eur J Cancer 242 (2026) 116818].

Corrigendum to "Association between chemotherapy use and prognosis in young patients with stage I-II ER+/HER2-negative breast cancer according to Prosigna®: An international real-world analysis with propensity-score matching" [Eur J Cancer 242 (2026) 116818].

CDK4/6i in the Underrepresented Histological Subtypes of HR±/HER2- Metastatic Breast Cancer: A Real-World Cohort Study of Effectiveness and Safety.

CDK4/6i in the Underrepresented Histological Subtypes of HR±/HER2- Metastatic Breast Cancer: A Real-World Cohort Study of Effectiveness and Safety.

Analysis of Large Language Model Decision Making in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer.

Analysis of Large Language Model Decision Making in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer.

Elacestrant in metastatic breast cancer: current advancements and future perspectives.

Elacestrant in metastatic breast cancer: current advancements and future perspectives.

Association between chemotherapy use and prognosis in young patients with stage I-II ER+ /HER2-negative breast cancer according to Prosigna®: An international real-world analysis with propensity-score matching.

Association between chemotherapy use and prognosis in young patients with stage I-II ER+ /HER2-negative breast cancer according to Prosigna®: An international real-world analysis with propensity-score matching.

Pharmacologic Features, Clinical Applications, and Drug Safety Evaluation of Inavolisib in the Treatment of Metastatic Breast Cancer.

Pharmacologic Features, Clinical Applications, and Drug Safety Evaluation of Inavolisib in the Treatment of Metastatic Breast Cancer.

Healthful and Unhealthful Plant-Based Diets and Their Association with Cardiometabolic Targets in Women Diagnosed with Breast Cancer: A Cross-Sectional Analysis of a Lifestyle Trial.

Healthful and Unhealthful Plant-Based Diets and Their Association with Cardiometabolic Targets in Women Diagnosed with Breast Cancer: A Cross-Sectional Analysis of a Lifestyle Trial.

Vitamin D Supplementation and Testosterone Levels in Breast Cancer Survivors.

Vitamin D Supplementation and Testosterone Levels in Breast Cancer Survivors.

Datopotamab deruxtecan: rational strategies, novel advancements, challenges, and future perspectives.

Datopotamab deruxtecan: rational strategies, novel advancements, challenges, and future perspectives.

Breast Immunology Network: Toward a Multidisciplinary and Integrated Model for Breast Cancer Care in Italy.

Breast Immunology Network: Toward a Multidisciplinary and Integrated Model for Breast Cancer Care in Italy.

Insights on the association of anthropometric and metabolic variables with tumor features and genomic risk in luminal early breast cancer: Results of a multicentric prospective study.

Insights on the association of anthropometric and metabolic variables with tumor features and genomic risk in luminal early breast cancer: Results of a multicentric prospective study.

The multidisciplinary management of HER2-positive breast cancer brain metastases: from new biological insights to future therapeutic options.

The multidisciplinary management of HER2-positive breast cancer brain metastases: from new biological insights to future therapeutic options.

Association between chemotherapy use and prognosis in young patients with stage I-II ER+ /HER2-negative breast cancer according to Prosigna®: An international real-world analysis with propensity-score matching.

Association between chemotherapy use and prognosis in young patients with stage I-II ER+ /HER2-negative breast cancer according to Prosigna®: An international real-world analysis with propensity-score matching.